{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d348aacb-00cd-4b2d-9b3b-ee9d99cdb735/688290a13781311f91f9d205?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Can a new drug help us to live longer? ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba18761a8cbe923a3cf195/1753387133411-80d50599-04a2-4995-82a1-228046c9a3b9.jpeg?height=200","description":"<p>The pharmaceutical industry is pursuing what some consider to be the holy grail: developing and licensing the first drug that slows the body's natural aging process.</p><p><br></p><p>Writer: Jon Ungoed-Thomas</p><p>Producer: Casey Magloire&nbsp;</p><p>Host: Tomini Babs&nbsp;</p><p>Executive Producer: Rebecca Moore&nbsp;</p><p><br></p>","author_name":"The Observer"}